Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Healthcare Agencies II01:17

Healthcare Agencies II

There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postoperative Pain Outcomes and Satisfaction in Preschool Versus School-Age Children: A Prospective Multicenter Observational Study.

Cureus·2026
Same author

Combination of the BK-Channel Antagonist ENA-001 and Naloxone Is More Effective Than Either Agent Alone in Reversing Fentanyl-Induced Respiratory Suppression in Rats.

Cureus·2026
Same author

Defining, Evaluating, and Managing Postoperative Respiratory Depression: An e-Delphi Study.

Cureus·2026
Same author

A Pilot Convenience Survey of Clinicians' Perception of the Desirability of a Lower Dose Option of an Opioid Analgesic: Hydrocodone as an Example.

Cureus·2026
Same author

Postoperative Pain Trajectories, Predictors of Severe Pain, and Satisfaction After Bariatric Surgery: A Prospective Multicenter Cohort Study.

Cureus·2026
Same author

Retrograde Type A Aortic Dissection With a Double Aortic Valve Sign Presenting As Acute Coronary Syndrome: A Case Report and Literature Review.

Cureus·2026

Related Experiment Video

Updated: May 14, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

Compounding pharmacies: who is in charge?

Joseph V Pergolizzi1, Sumedha Labhsetwar, Jo Ann LeQuang

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. jpjmd@msn.com

Pain Practice : the Official Journal of World Institute of Pain
|January 29, 2013
PubMed
Summary
This summary is machine-generated.

Compounding pharmacies are vital but face weak regulatory oversight, posing quality risks. Enhanced standards and clinician awareness are crucial for patient safety in pharmaceutical compounding.

More Related Videos

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Experiment Videos

Last Updated: May 14, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Area of Science:

  • Pharmaceutical Sciences
  • Healthcare Regulation
  • Clinical Pharmacy

Background:

  • Compounding pharmacies are increasingly integral to healthcare, supplying specialized medications.
  • Current regulatory frameworks, primarily Chapter <797> from the U.S. Pharmacopeial Convention, exhibit significant limitations in enforcement and scope.
  • Inconsistent state adoption and enforcement of Chapter <797> create variability in quality standards.

Purpose of the Study:

  • To highlight the expanding role of compounding pharmacies.
  • To identify and discuss the inadequacies in the current regulatory oversight of compounding pharmacies.
  • To underscore the potential quality and safety concerns associated with compounded medications.

Main Methods:

  • Analysis of existing regulatory guidelines, specifically Chapter <797>.
  • Review of media reports and common practices within the compounding pharmacy sector.
  • Assessment of the implications of current regulations on pharmaceutical quality and patient safety.

Main Results:

  • Chapter <797> is not universally mandated or stringently enforced across all states.
  • The existing standards lack robust requirements, such as mandatory drug lot number documentation and patient identification cross-referencing.
  • These regulatory gaps contribute to potential quality control issues in compounded sterile products.

Conclusions:

  • There is an urgent need for enhanced regulatory standards and enforcement for compounding pharmacies.
  • Clinicians require greater awareness regarding the origin and preparation methods of injectable products, particularly those from compounding pharmacies.
  • Improved regulation is essential to ensure the quality and safety of medications prepared by compounding pharmacies.